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High-throughput methods have made it possible to
generate microarrays carrying all ~4,000 proteins of
MMycobacterium tuberculosis (M.tb).W i t ht h i sp l a t -
form, large numbers of individual sera from infected
humans and animals can be tested for antibody detec-
tion. Preliminary results of probing M.tb proteome
microarrays with sera collected under a uniform study
protocol at various sites worldwide from > 500 pulmon-
ary TB suspects who received a final diagnosis of active
TB or non-TB-disease (NTBD) showed that approxi-
mately 500 M.tb proteins reacted with at least one
serum, while the rest of the proteome reacted to none.
Thus the immunoproteome of M.tb is approximately
one-tenth the size of the total proteome. It was also
found that, among the ~500 reactive proteins, only a
fraction reacted differentially to active TB sera versus
NTBD sera. It is intuitive that serodiagnostic antigens
belong to this antigen subset. Additionally, no obvious
pattern of reactivity was observed among active TB sera.
This result indicates that, within the pool of seroreactive
antigens, target recognition greatly varies from indivi-
dual to individual. We also explored the association
between proteome-scale antibody responses and clinical
and demographic covariates, such as patients’ age and
gender, country of origin, bacillary burden (expressed as
sputum smear grade), HIV status, etc. In particular, we
found that the antibody response to some antigens posi-
tively correlated with sputum smear grade, while the
response to others was independent of smear grade. The
previously reported positive correlation between reactiv-
ity to the 38 kDa antigen and bacillary burden supports
the proteome-wide results. We also observed that, while
antibody profiles varied among sera, antigens exhibiting
the highest differential ability were recognized across
geographical sites. Thus, it should be possible to identify
serodiagnostic antigens that can be utilized worldwide.
As previously reported, HIV co-infection dampened the
antibody response. Moreover, results of protein class
analysis showed that reactivity to the glyoxylate bypass
proteins was associated with active TB. This metabolic
pathway is essential for M.tb growth and survival in
mice, and is up-regulated in tubercle bacilli found in
human sputa. Thus, the analysis of antibody responses
at the proteome scale can be informative of the biology
of tubercle bacilli in the human host. In addition, pro-
teome microarray probing with sera from experimentally
infected macaques showed that antibody responses vary
with progression to disease, supporting the possibility
that disease progression can be monitored by serology.
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